Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.

The American journal of pathology - 1 Dec 2001

Saito T, Oda Y, Sugimachi K, Kawaguchi K, Tamiya S, Tanaka K, Matsuda S, Sakamoto A, Iwamoto Y, Tsuneyoshi M

Abstract excerpt

Synovial sarcoma is a mesenchymal tumor that has an epithelial character and two major histological subtypes, the biphasic type and the monophasic fibrous type. However, the mechanisms involved in its epithelial differentiation are unknown, and furthermore, the determinants for histological subty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to DNA, Neoplasm
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Polymorphism, Single-Stranded Conformational

Share to Prognosis

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to RNA, Messenger

Source

Open in PubMed Open full text

Identifiers

PMID: 11733362
DOI: 10.1016/s0002-9440(10)63063-5
PMCID: PMC1850581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11733362-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.PMID 11733362Read ↗

E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.Semantic proximity Read ↗

Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip.Semantic proximity Read ↗

Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition.Semantic proximity Read ↗

Gene Expression Profiling of Synovial Sarcoma: Distinct Signature of Poorly Differentiated TypeSemantic proximity Read ↗

BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma.Semantic proximity Read ↗

Expression of receptor tyrosine kinases epidermal growth factor receptor and HER‐2/<i>neu</i> in synovial sarcomaSemantic proximity Read ↗

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)Semantic proximity Read ↗

Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of ?-catenin mutations in synovial sarcomaSemantic proximity Read ↗

Predominantly epithelial-type synovial sarcoma with overwhelming neuroendocrine differentiation:a potential diagnostic pitfallSemantic proximity Read ↗

Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma.Semantic proximity Read ↗

Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma.Semantic proximity Read ↗

Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.